Best Cannabis HealthTech Companies in Canada
The 160 best Cannabis HealthTech companies in Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Canopy Growth.
Canada's Cannabis HealthTech sector is what this directory maps, ranking 160 tracked companies by disclosed equity funding and recent funding momentum, with Canopy Growth's $4.8B sitting so far ahead of the pack it warps the whole picture.
Total disclosed funding across the cohort hits $6.4B, and that number tells you something real about where capital has concentrated. Canopy Growth alone accounts for the lion's share, while Organigram at $504M is the clear second-tier anchor. Below that, you get a long tail: Zyus Life Sciences at $20M, Cannara Biotech at $18M, Avicanna at $6M, Predict Medix at $3M. No unicorns in the group, which I'd argue reflects how regulatory friction has kept valuations grounded even as the sector's projected CAGR hits ~76.8% globally. So what's actually moving this quarter? Policy is. Cannabis policy reform debates and legalization arguments are the loudest signals in the room right now, pulling investor attention and shaping which companies can scale. Favorable regulatory structures remain a core demand driver alongside rising chronic and neurological disorder rates. Active backers like RIV Capital, AmorChem, and Anges Quebec are watching that policy current closely, and if you're tracking where the next funding rounds land, that's the thread worth pulling.
Ranked: Best Cannabis HealthTech companies in Canada
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Canopy Growth Global cannabis company dedicated to improving lives through cannabis products 67Patents top 22%Funding top 24%Innovation top 32%Market top 33% All 12 signals ▾Patentstop 22% Fundingtop 24% Innovationtop 32% Markettop 33% Producttop 35% Moattop 35% Techtop 36% Newstop 37% Talenttop 45% Globaltop 50% Growthbottom 45% Fin. healthbottom 44% Patents: 490 patents matched (strict assignee match) · 181 filings since 2022 vs 307 in 2017-21 Funding: Raised $4.8B across 9 rounds · 9 rounds over 10 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 67/100 | $4.8B | 29 mo ago | 170 | 2013 | Mark Zekulin Co-Founder | 35 signals ▼35% Earnings · M&A · Board | 490 patents Cannabinoid-derived pharmaceuticals, water‑soluble formulations, vaporizer devices, mildew‑resistant cannabis strains | 2 launchs · 2 expansions |
| 2 | Aphria Provider of cannabis-derived nutritional and wellness products 57Funding top 22%Market top 34%Moat top 47%Patents top 48% All 7 signals ▾Fundingtop 22% Markettop 34% Moattop 47% Patentstop 48% Talentbottom 49% Innovationbottom 44% Globalbottom 43% Funding: Raised $536M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) Market: 300 employees (top 13% of HealthTech) rank vs industry peers · Fliar Intelligence Index 57/100 | $536M | 85 mo ago | 300 | 2014 | Cole Cacciavillani Co-Founder | — | 3 patents Aerosol atomizer packaging technology for controlled dispensing | — |
| 3 | Organigram Global cannabis leader driving innovation, operational excellence, and shaping the industry 72Funding top 19%Product top 24%News top 35%Tech top 37% All 11 signals ▾Fundingtop 19% Producttop 24% Newstop 35% Techtop 37% Innovationtop 38% Growthtop 38% Patentstop 38% Markettop 41% Moattop 42% Talenttop 42% Globalbottom 39% Funding: Raised $504M across 14 rounds · 14 rounds over 12 yrs (1.2/yr) Product: 3 product launch events in 12 mo · 10 distinct product lines rank vs industry peers · Fliar Intelligence Index 72/100 | $504M | 15 mo ago | 923 | 2013 | Icd Beena Goldenberg Chief Executive Officer | 30 signals Earnings · M&A · Leadership | 10 patents Cannabinoid emulsions and buccal delivery formulations for oral and topical use | — |
| 4 | MediPharm Labs Manufacturer of pharma-quality cannabis API and cannabinoid-based derivative products 40Funding top 26%Talent top 42%News top 44%Moat top 48% All 8 signals ▾Fundingtop 26% Talenttop 42% Newstop 44% Moattop 48% Markettop 49% Globalbottom 44% Techbottom 43% Growthbottom 32% Funding: Raised $160M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 40/100 | $160M | 58 mo ago | 130 | 2016 | David Pidduck Chief Executive Officer | 9 signals ▼67% Earnings · Leadership | — | 1 job opening |
| 5 | Inversago Pharma Peripheral cannabinoid (CB1) receptor antagonist/inverse agonist for the treatment of metabolic diseases | $115M | 44 mo ago | 25 | 2015 | — | — | 20 patents Development of small‑molecule CB1 receptor antagonists and related heterocyclic drug candidates | — |
| 6 | Tetra Bio-Pharma Developer of natural medicinal plant-based elements for treating multiple diseases 32Funding top 26%Talent bottom 49%Market bottom 41%Tech bottom 38% All 6 signals ▾Fundingtop 26% Talentbottom 49% Marketbottom 41% Techbottom 38% Globalbottom 36% Newsbottom 24% Funding: Raised $37.9M across 7 rounds · 7 rounds over 8 yrs (0.9/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 32/100 | $38M | 39 mo ago | 33 | 2015 | Andre Audet Co-Founder | — | — | — |
| 7 | JWC Producer and supplier of cannabis products | $35M | 75 mo ago | 85 | 2008 | — | — | — | — |
| 8 | Dionymed Platform offering support services to cannabis cultivators | $31M | 80 mo ago | 5 | 2017 | Edward M. Fields CEO | — | — | — |
| 9 | Alternate Health Manufacturer and distributor of CBD-infused products for consumers | $24M | 76 mo ago | — | 2014 | Howard Mann Founder & CEO | — | — | — |
| 10 | Aleafia Health Cultivator and producer of cannabis plant for consumer wellness and research applications | $23M | 47 mo ago | 158 | 2007 | — | — | — | — |
| 11 | ZYUS Life Sciences Developer of cannabis-derived therapeutics for multiple indications 62News top 17%Funding top 21%Patents top 24%Growth top 25% All 10 signals ▾Newstop 17% Fundingtop 21% Patentstop 24% Growthtop 25% Moattop 32% Innovationtop 33% Talentbottom 49% Techbottom 48% Globalbottom 43% Marketbottom 39% News: 6 BI events in 12 mo (of 20 tracked, 6 types) · +200% YoY Funding: Raised $19.5M across 9 rounds · 9 rounds over 7 yrs (1.3/yr) rank vs industry peers · Fliar Intelligence Index 62/100 | $20M | 3 mo ago | 51 | 2018 | Brent Zettl Founder & CEO | 6 signals ▲200% Funding · Announcements | 45 patents Cannabinoid formulations for pain relief and migraine treatment | — |
| 12 | Delta 9 Cannabis Online pharmacy for cannabis wellness and recreational products | $18M | 45 mo ago | 81 | 2012 | Bill Arbuthnot Co-Founder | — | — | — |
| 13 | Nutritional High Provider of cannabis infused product development and distribution services | $18M | 70 mo ago | 10 | 2004 | — | — | — | — |
| 14 | Cannara Biotech Producer of premium‐grade cannabis and cannabis‐derivative products 53Product top 14%Funding top 24%Innovation top 34%News top 34% All 9 signals ▾Producttop 14% Fundingtop 24% Innovationtop 34% Newstop 34% Moattop 39% Growthtop 47% Marketbottom 44% Techbottom 42% Globalbottom 36% Product: 5 distinct product lines · Company stage: Public Funding: Raised $17.7M across 5 rounds · 5 rounds over 8 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 53/100 | $18M | 4 mo ago | 54 | 2018 | — | 16 signals Earnings · Regulatory · Announcements | — | 1 partnership |
| 15 | Canada House Cannabis-focused marketplace | $15M | 71 mo ago | — | 2003 | — | — | — | — |
| 16 | Terrace Global Developer of recreational cannabis and medical cannabis products | $15M | 69 mo ago | — | 2018 | Francisco Ortiz Co-Founder | — | — | — |
| 17 | Hyasynth Bio Developer of cannabinoid products intended to treat neurological disorders | $11M | 53 mo ago | 18 | 2014 | Zach Wiltshire Co-Founder & COO | — | — | — |
| 18 | PharmHouse Developer of greenhouse cannabis cultivation facilities | $10M | 69 mo ago | 23 | 2018 | — | — | — | — |
| 19 | Global Cannabis Applications Corporation Data source provider for medical cannabis community | $8M | 90 mo ago | — | 2015 | Bradley Moore CEO | — | 2 patents Cannabis cultivation product tracking and traceability systems using RFID/barcode technology | — |
| 20 | Verdemed Medical cannabis company | $7M | 87 mo ago | 14 | 2014 | — | — | — | — |
| 21 | Avicanna Developer of plant-derived cannabinoid-based products 67Growth top 15%News top 24%Funding top 29%Talent top 36% All 10 signals ▾Growthtop 15% Newstop 24% Fundingtop 29% Talenttop 36% Patentstop 37% Moattop 38% Innovationtop 40% Techtop 48% Marketbottom 44% Globalbottom 39% Growth: Fresh capital in last 24 mo News: 12 BI events in 12 mo (of 54 tracked, 9 types) · +140% YoY rank vs industry peers · Fliar Intelligence Index 67/100 | $6M | 4 mo ago | 80 | 2016 | Aras Azadian Chief Executive Officer | 12 signals ▲140% Leadership · Earnings | 16 patents Cannabinoid pharmaceutical formulations for neurological, pain, skin, and epilepsy therapies | — |
| 22 | Biorthex Developer of bio-materials for orthopedic applications | $6M | 333 mo ago | 11 | 1993 | Charles Rivard Founder | — | 10 patents Porous nickel‑titanium biomedical implants for spinal disc replacement. | — |
| 23 | Canadian Cannabis Corp Manufacturer of medical marijuana products, including dried strains and chemical variants | $5M | 145 mo ago | 9 | 2014 | — | — | — | — |
| 24 | Canntab Therapeutics Provider of solid oral dose formulations of cannabis products | $5M | 52 mo ago | — | 2010 | Richard Goldstein Co-Founder | — | 24 patents Formulation technologies for oral cannabinoid dosage forms (immediate, sustained, multi‑layer). | — |
| 25 | Resolve Digital Health Developer of a smart inhaler | $5M | 83 mo ago | — | 2015 | Rob Adelson CEO | — | 28 patents Integrated inhalation/vaporization devices with digital health monitoring and data analytics | — |
| 26 | Orcosa Developer of cannabinoid-based therapeutics for oncology and neurological disorders | $4M | 17 mo ago | 15 | 2020 | Bryan Ridall CEO & President | — | — | — |
| 27 | Predict Medix Inc AI-powered contactless screening solutions for workplace 24News top 25%Product top 35%Moat top 38%Funding top 41% All 7 signals ▾Newstop 25% Producttop 35% Moattop 38% Fundingtop 41% AItop 45% Marketbottom 31% Globalbottom 30% News: 3 BI events in 12 mo (of 21 tracked, 7 types) · +200% YoY Product: 0 product launch events in 12 mo · Company stage: Public rank vs industry peers · Fliar Intelligence Index 24/100 | $3M | 14 mo ago | 11 | 2018 | — | 3 signals ▲200% Funding · Announcements | — | — |
| 28 | FluroTech Provider of fluorescence spectroscopy-based technology solutions | $3M | 25 mo ago | 18 | 2018 | Danny Longa Co-Founder & CEO | — | — | — |
| 29 | Dynaleo Developer of cannabis based edible products | $2M | 38 mo ago | 34 | 2018 | — | — | — | — |
| 30 | GrowerIQ Provider of seed-to-sale and cannabis cultivation management software | $2M | 45 mo ago | 30 | 2018 | Andrew Wilson Founder & CEO | — | — | — |
| 31 | CannaVcell Provides patented technology for bio-harvesting cannabis | $2M | 74 mo ago | — | 2013 | Yochi Hagay Co-Founder | — | — | 2 partnerships |
| 32 | Hempsana Provider of solution to process CBD oil form hemp plants | $1M | 63 mo ago | 5 | 2018 | Randy Ko Co-Founder & CEO | — | — | — |
| 33 | Citation Growth Online retailer of domain names with various purchasing and financing options | $1M | 79 mo ago | — | 2019 | Rahim Mohamed Co-CEO | — | — | — |
| 34 | HEMPALTA Hemp-based agricultural cleantech company providing carbon credit solutions and sustainable products 24Funding top 43%News top 47%Growth top 50%Talent bottom 49% All 7 signals ▾Fundingtop 43% Newstop 47% Growthtop 50% Talentbottom 49% Techbottom 43% Globalbottom 36% Marketbottom 26% Funding: Raised $1.0M across 1 rounds · 1 rounds over 3 yrs (0.3/yr) News: 5 BI events in 12 mo (of 21 tracked, 8 types) · -38% YoY rank vs industry peers · Fliar Intelligence Index 24/100 | $1M | 16 mo ago | 11 | 2022 | Darren Bondar Founder & CEO | 5 signals ▼38% Board · Announcements · Regulatory | — | — |
| 35 | Greenline Provider of web platform and compliance support services for cannabis retailers | $1M | 55 mo ago | 32 | 2017 | Albert Kim CEO | — | — | — |
| 36 | YOOMA Provider of digital marketing for multiple brands related to cannabis health products | $1M | 58 mo ago | 5 | 2019 | Andres Mcdonald Owner | — | — | — |
| 37 | Beleave Provider of cannabis products bridging science and tradition for investment | $1M | 96 mo ago | 18 | 2000 | Roger Emmanuel Ferreira Co-Founder | — | 8 patents Cannabinoid extraction, purification, and pharmaceutical formulation technologies. | — |
| 38 | Aion Therapeutic Provider and manufacturer of cannabis-based nutraceutical products for diverse diseases | $868K | 25 mo ago | — | 2011 | Graham Simmonds CEO | — | — | — |
| 39 | Zentrela Provider of device to measure the psychoactive effects of cannabis on the brain | $850K | 64 mo ago | 7 | 2015 | — | — | 3 patents EEG-based assessment of psychoactive drug effects for neuropharmacology and clinical monitoring | — |
| 40 | Lift Provider of online cannabis related information portal for consumers and retailers | $763K | 81 mo ago | 60 | 2013 | — | — | 5 patents Multifunction hydraulic valve assemblies for fluid power control systems | — |
| 41 | AIMA Provider of cannabis-infused products for menstrual pain management | $601K | 41 mo ago | — | 2019 | Lanna Last Co-Founder | — | — | — |
| 42 | Next Green Wave Authentic Neapolitan pizza with rhythmic freedom, quality ingredients, and unique flavors | $576K | 78 mo ago | 4 | 2017 | — | — | — | — |
| 43 | PlantEXT Developer of cannabis-based medical products targeting inflammation-related conditions and unmet needs | $500K | 83 mo ago | 10 | 2015 | Oded Sagee Founder | — | — | — |
| 44 | Ample Organics ERP software for cannabis industry | $445K | 80 mo ago | 44 | 2014 | — | — | — | — |
| 45 | EFX Labs Provider of cannabis infused capsules for consumer usage | $370K | 103 mo ago | 3 | 2017 | Jeff Galatiuk Founder | — | — | — |
| 46 | CertiCraft Provider of seed-to-sale compliance solution for cannabis businesses | $150K | 51 mo ago | 11 | 2018 | Nicholas Wong Co-Founder | — | — | 1 job opening · 2 launchs |
| 47 | Pike Therapeutics Developer of psychedelic and cannabinoid therapeutics | $100K | 18 mo ago | 3 | 2019 | Brad Miles Co-Founder & CEO | — | 100 patents Transdermal cannabinoid delivery systems for neurological and chronic pain therapies | — |
Top 12 Cannabis HealthTech companies in Canada
#1
Public · Saskatoon, Saskatchewan · founded 2018 · 51 employees$19.5Mraised▾
Developer of cannabis-derived therapeutics for multiple indications. The company is focusing on the development of cannabinoid-based therapeutics and protein-based formulations to provide targeted relief for patients. The company's lead drug candidate is Trichomylin to alleviate chronic pain.
- Mar 2026Post IPO$207K
- Nov 2025Post IPO$1.1M
- Jul 2025Post IPO$233K
- Jun 2025Post IPO$182.4K
#2
Public · Moncton, New Brunswick · founded 2013 · 923 employees$503.7Mraised▾
Global cannabis leader driving innovation, operational excellence, and shaping the industry. The company redefines the cannabis sector through innovative products, beloved consumer brands, and a growing international presence. They push the boundaries of cannabis cultivation and product development, using a scientific approach and cutting-edge technology to bring high-quality products to consumers. Their portfolio includes popular brands, each offering exceptional quality and unique experiences. They strategically invest in and partner with companies to extend their reach beyond Canada, bringing their products, brands, and intellectual property to new markets. They envision a future where cannabis is embraced as a mainstream consumer choice with broader market access and responsible regulation. They are adapting to the consumer of tomorrow, prioritizing experience and seeing cannabis as an alternative to traditional products. They are committed to making a positive impact in their communities through social impact initiatives.
- Feb 2025Post IPO$29M
- Aug 2024Post IPO$30.8M
- Jan 2024Post IPO$30.8M
- Mar 2021Post IPO$175M
#3
Public · Montreal, Montreal · founded 2018 · 54 employees$17.7Mraised▾
Producer of premium‐grade cannabis and cannabis‐derivative products. The company offer a variety of organic cannabis-infused with medicinal herbs and flowers. The company offerings span dried flower, pre-rolls, hash, rosin, live resin extracts, oils, and accessories, all hang-dried, hand-trimmed, and slow-cured for potency and terpene preservation.
- Feb 2026Post IPO$4.6M
- Jul 2021Post IPO$5M
- Oct 2019Conventional Debt$6M
- Jul 2019Post IPO$2.2M
#4
Public · Toronto, Ontario · founded 2016 · 80 employees$5.9Mraised▾
Developer of plant-derived cannabinoid-based products. The company develops advanced cannabinoid formulations and delivery mechanisms for medical applications and consumer products. It markets its cannabinoid-based solutions to a range of channels and markets including derma-cosmetics, phytotherapeutics, and pharmaceutical solutions.
- Feb 2026Post IPO$1.1M
- Jul 2025Post IPO$729.7K
- Nov 2024Post IPO$573.3K
- Aug 2024Post IPO$1.5M
#5
Public · Smiths Falls, Ontario · founded 2013 · 170 employees$4.8Braised▾
Global cannabis company dedicated to improving lives through cannabis products. Focused on unlocking the power of cannabis, the company offers high-quality products with best-in-class cannabinoid effects. Rooted in the belief that cannabis can enhance every moment, they are redefining experiences and demonstrating the true potential of this powerful plant. The company is committed to personal wellness, fostering economic opportunity, and striving towards social justice. They aim to serve as a new model for a transformational industry, building an organization made with intention and defined by purpose. The leadership team leverages extensive experience from various industries to innovate and create long-term value for consumers, employees, and shareholders.
- Jan 2024Post IPO$35M
- Feb 2023Post IPO—
- May 2020Post IPO$176.3M
- Aug 2018Post IPO$4B
#6
Public · Toronto, Ontario · founded 2018 · 11 employees$2.8Mraised▾
AI-powered contactless screening solutions for workplace. The company's products include Infectious disease screening, cannabis and alcohol impairment screening, and mobilewellbeing to measure body vitals of users.
- Apr 2025Post IPO$70K
- Mar 2025Post IPO$283.6K
- Feb 2025Post IPO$224.8K
- Feb 2023Post IPO$612.5K
#7
Series B · Canada · founded 2020 · 15 employees$3.5Mraised▾
Developer of cannabinoid-based therapeutics for oncology and neurological disorders. The company has developed non-opioid analgesics based on rapid infusion technology. It targets CB1 and CB2 receptors to treat traumatic brain injury, neurodegenerative disease, and tumors.
- Dec 2024Series B$7.3M
- Sep 2021Series B$11.3M
#8
Public · Leamington, Ontario · founded 2014 · 300 employees$535.8Mraised▾
Provider of cannabis-derived nutritional and wellness products. The company offers CBD oil, tincture, gel capsules,pre-rolls, cartridges, flowers, and topicals. It helps in alleviating pain, anxiety, sleep disorders, PTSD, and addiction.
- Apr 2019Post IPO$300M
- Jul 2018Conventional Debt$25M
- Jun 2018Post IPO$173.6M
- May 2017Conventional Debt$25M
#9
Public · Calgary, Alberta · founded 2022 · 11 employees$1Mraised▾
Hemp-based agricultural cleantech company providing carbon credit solutions and sustainable products. It leverages the hemp value chain to generate global carbon credit solutions, pioneering the use of industrial hemp in the voluntary carbon market. The company combines hemp cultivation with biochar application for soil health and carbon sequestration. It offers a diverse range of hemp-based commercial and consumer products for a healthier, more sustainable future. The company is focused on innovating the global hemp carbon credit industry and utilizing advanced agricultural technology to process hemp at scale. It also provides consumer products, eco-building materials, and animal bedding. The website has features like search, cart, login, investor relations, press releases, and contact information.
- Jan 2025Post IPO$1M
- Feb 2023Post IPO—
#10
Series C · Montreal, Montreal · founded 2015 · 25 employees$114.8Mraised▾
Inversago Pharma (formerly GIcare Pharma) is focused on developing peripheral cannabinoid (CB1) receptor antagonist/inverse agonist for the treatment of metabolic diseases such as obesity, insulin resistance, and liver fibrosis. Its drug INV-101 (Inverse agonist of peripheral CB1) under phase-1.
- Oct 2022Series C$70M
- Sep 2020Series B$37.8M
- Jul 2018Series A$7M
#11
Public · Barrie, Ontario · founded 2016 · 130 employees$159.8Mraised▾
Manufacturer of pharma-quality cannabis API and cannabinoid-based derivative products. The company formulates, tests, processes, packages, and distributes cannabis extracts. It offers wholesale and white label platforms from its certified facilities. The company utilizes extraction, distillation, and purification for cannabinoid isolation. It also conducts research and development for sensory testing of products.
- Aug 2021Grant (prize money)$239.2K
- Mar 2021Post IPO$33M
- Jun 2020Post IPO$28.2M
- Oct 2019Conventional Debt$38.7M
#12
Public · Ottawa, Ontario · founded 2015 · 33 employees$37.9Mraised▾
Developer of natural medicinal plant-based elements for treating multiple diseases. It engaged in the development of biopharmaceuticals and natural health products containing Cannabis and other medicinal plant-based elements. Its drug pipeline includes PPP001, a smokable bio-cannabis pharmaceutical for chronic pain, PPP002 to treat Insomnia, and PTSD in chronic pain patients, and PPP003 for chronic pain, PTSD, and other neurologic and psychiatric conditions. The company also develops natural health products for skin care, pain management, etc.
- Mar 2023Grant (prize money)—
- Aug 2022Post IPO—
- May 2022Post IPO$7.5M
- Jan 2021Post IPO$1.9M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Cannabis HealthTech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.